Global Anti-Emetic Drugs Market - Industry trends and Forecast to 2027

  • Pharmaceutical
  • Upcoming Report
  • Apr 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Anti-Emetic Drugs Market, By Indication (Chemotherapy, Motion Sickness, Gastroenteritis, Dizziness, Pregnancy, Food Poisoning, Others), Drug Class (Prokinetics, Serotonin Antagonists, Antimuscarinics, Antihistaminic, Neurokinin Antagonists, Others),  Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa)-Industry trends and Forecast to 2027

Market Analysis and Insights: Global Anti-Emetic Drugs Market

Global Anti-emetic Drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market.

The global anti-emetic drugs market is majorly driven by high prevalence of cancer where chemotherapy is dominant treatment as nausea and vomiting is common side effects, high diagnostics rate and vulnerable geriatric population. Nevertheless, limited revenue opportunities coupled with patent expiration and shortage of drugs are some of the prominent factors that hinder the growth of this market.

Anti-emetic is a therapeutic drug used effectively for the treatment of vomiting and nausea. These agents exert their effect by interfering neurotransmitter receptors that present in the brain and involved in the action of vomiting and nausea. It is commercially available as over-the-counter and prescribed drug.

Global anti-emetic drugs market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Anti-Emetic Drugs Market Scope and Market Size

Global anti-emetic drugs market is segmented on the basis of indication, drug class, route of administration, end-users and distribution channel.

  • Based on indication, the global anti-emetic drugs market is segmented into chemotherapy, motion sickness, gastroenteritis, dizziness, pregnancy, food poisoning and others.
  • Drug class for the global anti-emetic drugs market is segmented into prokinetics, serotonin antagonists, antimuscarinics, antihistaminic, neurokinin antagonists and others.
  • The route of administration segment for global anti-emetic drugs market is segmented into oral, parenteral and others.
  • On the basis of end-users, the global anti-emetic drugs market is segmented into hospitals, homecare, speciality centres and others.
  • On the basis of distribution channel, the global anti-emetic drugs market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy.

Global Anti-Emetic Drugs Market Country Level Analysis

Global anti-emetic drugs market is analyzed and market size information is provided by country, indication, drug class, route of administration, end-users and distribution channel as referenced above.

The countries covered in the global anti-emetic drugs market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

Based on geography, North America represent high market share for global anti-emetic drugs market due to the established regulatory framework, favourable govt support, rise in adoption of newer technologies, presence of refined healthcare infrastructure and increased patient awareness level as well as high prevalence of cancer. Europe is considered a second largest growing regional segment owing to the presence of global marketed players in this region and surge in population. Asia Pacific leads the market due to the rise in number of generic manufacturers in this region as well as increasing disposable income.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Global anti-emetic drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Anti-Emetic Drugs Market Share Analysis

Global anti-emetic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global anti-emetic drugs market.

The major players covered in the global anti-emetic drugs market are Merck & Co., Inc., Novartis AG, Glenmark Pharmaceuticals Limited, F. Hoffmann-La Roche Ltd, Heron Therapeutics, Inc, Kyowa Kirin Co., Ltd, Aurobindo Pharma, Mylan N.V., Hikma Pharmaceutical Plc, Akorn Incorporated, Dr. Reddy’s Laboratories Ltd, Cipla Inc, Fresenius Kabi AG, Wockhardt, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Pfizer Inc and others.

Customization Available: Global Anti-Emetic Drugs Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions